Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Although nanomedicine-based delivery of 2-DG could significantly reduce its systemic exposure and lower off-target neurotoxicity by improving tumor accumulation and controlled release, current nanomedicines failed to completely eliminate the risk of neurotoxicity, especially at higher doses or during repeated administration
Please enter the correct identification code in the search area to query the relevant documents
The FDA decision is anticipated in 3Q2025
Malware Analysis, News and Indicators Pre-approved GLP-1 prescription scam could be bad for your health Malware News MalBot September 10, 2025, 1:25pm 1 A co-worker received a text which is, unfortunately, becoming more common
US$ 25.89
US$ 22.22
US$ 22.19
